Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa single-arm trial of CKBA cream for papulopustular rosacea
ChiCTR2600119496Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ciklentanilic acid in papulopustular rosacea, sponsored by West China Hospital of Sichuan University. Primary endpoints: Change in inflammatory lesion count at 16 weeks and Proportion of subjects with IGA 0 or 1 at 16 weeks. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
ciklentanilic acid
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on ChiCTR2600119496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119496.